Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 20 results.
User Information
Export Records
  1. 1.   Meeting report: Third Summer School on Innovative Approaches for Identification of Antiviral Agents (IAAASS)
  2. Legrice, Stuart; Sztuba-Solinska, Joanna; Maccioni, Elias; Purzycka, Katarzyna J; Parolin, Cristina; Tramontano, Enzo
  3. Antiviral research. 2017, Mar; 139: 13-17.
  1. 2.   Ionic Liquids: Neoteric Solvents for Nucleoside Chemistry
  2. Kumar, V.; Parmar, V. S.; Malhotra, S. V.
  3. Current Organic Synthesis. 2011, Dec; 8(6): 777-786.
  1. 3.   Structural modifications of nucleosides in ionic liquids
  2. Kumar, V.; Parmar, V. S.; Malhotra, S. V.
  3. Biochimie. 2010, Sep; 92(9): 1260-1265.
  1. 4.   Application of Halide Molten Salts as Novel Reaction Media for O-Glycosidic Bond Formation
  2. Kumar, V.; Talisman, I. J.; Malhotra, S. V.
  3. European Journal of Organic Chemistry. 2010, Jun; (18): 3377-3381.
  1. 5.   Synthesis of nucleoside-based antiviral drugs in ionic liquids
  2. Kumar, V.; Malhotra, S. V.
  3. Bioorganic & Medicinal Chemistry Letters. 2008 18(20): 5640-5642.
  1. 6.   Morphological and molecular course of mitochondrial pathology in cultured human cells exposed long-term to zidovudine
  2. Divi, R. L.; Haverkos, K. J.; Humsi, J. A.; Shockley, M. E.; Thamire, C.; Nagashima, K.; Olivero, O. A.; Poirier, M. C.
  3. Environmental and Molecular Mutagenesis. 2007, Apr-May; 48(3-4): 179-189.
  1. 7.   Chemical library screen for novel inhibitors of Kaposi's sarcoma-associated herpesvirus processive DNA synthesis
  2. Dorjsuren, D.; Burnette, A.; Gray, G. N.; Chen, X. L.; Zhu, W. M.; Roberts, P. E.; Currens, M. J.; Shoemaker, R. H.; Ricciardi, R. P.; Sei, S.
  3. Antiviral Research. 2006, JAN; 69(1): 9-23.
  1. 8.   Potent antiviral activity of North-methanocarbathymidine against Kaposi's sarcoma-associated herpesvirus
  2. Zhu, W. M.; Burnette, A.; Dorjsuren, D.; Roberts, P. E.; Huleihel, M.; Shoemaker, R. H.; Marquez, V. E.; Agbaria, R.; Sei, S.
  3. Antimicrobial Agents and Chemotherapy. 2005, DEC; 49(12): 4965-4973.
  1. 9.   A novel and efficient approach to discriminate between pre- and post-transcription HIV inhibitors
  2. Daelemans, D.; Pannecouque, C.; Pavlakis, G. N.; Tabarrini, O.; De Clercq, E.
  3. Molecular Pharmacology. 2005, MAY; 67(5): 1574-1580.
  1. 10.   Discovery of small-molecule human immunodeficiency virus type 1 entry inhibitors that target the gp120-binding domain of CD4
  2. Yang, Q. E.; Stephen, A. G.; Adelsberger, J. W.; Roberts, P. E.; Zhu, W. M.; Currens, M. J.; Feng, Y. X.; Crise, B. J.; Gorelick, R. J.; Rein, A. R.; Fisher, R. J.; Shoemaker, R. H.; Sei, S.
  3. Journal of Virology. 2005, MAY; 79(10): 6122-6133.
  1. 11.   Dynamics of the antiviral activity of N-methanocarbathymidine against herpes simplex virus type 1 in cell culture
  2. Huleihel, M.; Talishanisky, M.; Ford, H.; Marquez, V. E.; Kelley, J. A.; Johns, D. G.; Agbaria, R.
  3. International Journal of Antimicrobial Agents. 2005, MAY; 25(5): 427-432.
  1. 12.   Design and synthesis of novel indole beta-diketo acid derivatives as HIV-1 integrase inhibitors
  2. Sechi, M.; Derudas, M.; Dallocchio, R.; Dessi, A.; Bacchi, A.; Sannia, L.; Carta, F.; Palomba, M.; Ragab, O.; Chan, C.; Shoemaker, R.; Sei, S.; Dayam, R.; Neamati, N.
  3. Journal of Medicinal Chemistry. 2004, OCT 7; 47(21): 5298-5310.
  1. 13.   Eradication of HIV in infected patients: Some potential approaches
  2. Yang, Q. E.
  3. Medical Science Monitor. 2004, JUL; 10(7): RA155-RA165.
  1. 14.   Discovery of a novel class of small-molecule HIV entry inhibitors that target the gp120-binding domain of CD4
  2. Yang, Q.; Roberts, P.; Zhu, W.; Stephen, A.; Adelsberger, J.; Currens, M.; Feng, Y.; Fisher, R.; Rein, A.; Shoemaker, R.; Sei, S.
  3. Antiviral Research. 2004 62(2): A28-A28.
  1. 15.   Rational design and synthesis of novel dimeric diketoacid-containing inhibitors of HIV-1 integrase: Implication for binding to two metal ions on the active site of integrase
  2. Long, Y. Q.; Jiang, X. H.; Dayam, R.; Sanchez, T.; Shoemaker, R.; Sei, S.; Neamati, N.
  3. Journal of Medicinal Chemistry. 2004 47(10): 2561-2573.
  1. 16.   An inhibitor of glycosphingolipid metabolism blocks HIV-1 infection of primary T-cells
  2. Puri, A.; Rawat, S. S.; Lin, H. M. J.; Finnegan, C. A.; Mikovits, J.; Ruscetti, F. W.; Blumenthal, R.
  3. Aids. 2004 18(6): 849-858.
  1. 17.   Human immunodeficiency virus reservoir might be actively eradicated as residual malignant cells by cytotoxic chemotherapy
  2. Yang, Q.
  3. Medical Hypotheses. 2004 62(3): 358-363.
  1. 18.   Peptide nucleic acids as epigenetic inhibitors of HIV-1
  2. Sei, S.
  3. Letters in Peptide Science. 2003 10(3-4): 269-286.
  1. 19.   Potential drugs against cervical cancer: Zinc-ejecting inhibitors of the human papillomavirus type 16 E6 oncoprotein
  2. Beerheide, W.; Bernard, H. U.; Tan, Y. J.; Ganesan, A.; Rice, W. G.; Ting, A. E.
  3. Journal of the National Cancer Institute. 1999 91(14): 1211-1220.
  1. 20.   Binding Between the Cd4 Receptor and Polysulfonated Azo-Dyes - an Exploratory Theoretical Study On Action-Mechanism
  2. Szekely, Z.; Fabian, P.; Torday, L. L.; Michejda, C. J.; Aszalos, A.
  3. Theochem-Journal of Molecular Structure. 1998 423(1-2): 153-159.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel